Stress hyperglycemia ratio (SHR), calculated by dividing admission glucose levels by estimated chronic glucose levels, has emerged as a novel marker of glycemic stress. However, its prognostic value in patients… Click to show full abstract
Stress hyperglycemia ratio (SHR), calculated by dividing admission glucose levels by estimated chronic glucose levels, has emerged as a novel marker of glycemic stress. However, its prognostic value in patients hospitalized with COVID‐19 remains unclear. This meta‐analysis investigates the association between SHR and adverse outcomes in this population.
               
Click one of the above tabs to view related content.